Carotid Stenosis: Clinical Trials

7 trials for Carotid Stenosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 withdrawn, 2 completed, 2 unknown. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Withdrawn 3, Completed 2, Unknown 2
Phase 22Withdrawn 2

Follow Carotid Stenosis: new trials by email Literature Review of Carotid Stenosis trials Research Report on Carotid Stenosis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque
Qushi Formula, Zhu's Wenban Formula, placebo - Protein; Disease, Carotid Artery Plaque
Phase 1UnknownGuangzhou University of Traditional Chinese Medicine3002023-05-312023-03-14
Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting
Ticagrelor, Clopidogrel, Carotid stenting - Carotid Stenosis
Phase 1UnknownAssiut University262022-01-012021-03-23
Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque
Indocyanine green - Atherosclerosis, Atherosclerotic Plaque
Phase 1CompletedMassachusetts General Hospital52013-05-012017-02-02
Lucentis for New Onset Neovascular Glaucoma
Ranibizumab (Lucentis) - Glaucoma, New Onset Glaucoma
Phase 1 / Phase 2WithdrawnUniversity of Illinois at Chicago2008-01-042020-02-17
Study of Early Versus Delayed Carotid Endarterectomy (CEA) for Small to Medium-sized Ischemic Stroke Caused by High-grade Carotid Stenosis
carotid endarterectomy - Stroke, Carotid Stenosis
Phase 1WithdrawnUniversity of California, San Diego2006-04-012015-02-04
Potential Risk Factors for Stroke
cytokine and leukocyte activation profile - Carotid Atherosclerosis, Cerebrovascular Accident
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)5001993-10-012008-03-04
Stroke Prevention With Abciximab in Carotid Endarterectomy
Abciximab - Carotid Stenosis
Phase 1 / Phase 2WithdrawnUniversity of Rochester2015-12-18

Narrower conditions

Atherosclerosis (2)  ·  Stroke (2)  ·  Brain Ischemia (1)  ·  Carotid Artery Diseases (1)  ·  Diabetes Mellitus (1)  ·  Disease (1)  ·  Glaucoma (1)  ·  Glaucoma, Neovascular (1)  ·  Hypercholesterolemia (1)  ·  Hypertension (1)  ·  Inflammation (1)  ·  Plaque, Atherosclerotic (1)  ·  Retinal Vein Occlusion (1)

Broader conditions

Arterial Occlusive Diseases (7)  ·  Brain Diseases (7)  ·  Cardiovascular Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Cerebrovascular Disorders (7)  ·  Nervous System Diseases (7)  ·  Vascular Diseases (7)  ·  Carotid Artery Diseases (6)  ·  Arteriosclerosis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Dyslipidemias (1)  ·  Embolism and Thrombosis (1)  ·  Endocrine System Diseases (1)  ·  Eye Diseases (1)

Interventions

Abciximab (1)  ·  Clopidogrel (1)  ·  Cytokines (1)  ·  Endarterectomy, Carotid (1)  ·  Indocyanine Green (1)  ·  Ranibizumab (1)  ·  Ticagrelor (1)

Sponsors

Assiut University (1)  ·  Guangzhou University of Traditional Chinese Medicine (1)  ·  Massachusetts General Hospital (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  University of California, San Diego (1)  ·  University of Illinois at Chicago (1)  ·  University of Rochester (1)

Countries

United States (4)  ·  China (1)

Top investigators

Farouc A Jaffer, MD PhD (1)  ·  Matt B Jensen, MD (1)  ·  Michael P Blair, MD (1)  ·  William S Burgin, MD (1)

Results publications

PMID 27544892